ATE234111T1 - Therapeutische verwendungen von bpi-protein produkten bei menschen mit durch trauma verursachter blutung - Google Patents
Therapeutische verwendungen von bpi-protein produkten bei menschen mit durch trauma verursachter blutungInfo
- Publication number
- ATE234111T1 ATE234111T1 AT97929697T AT97929697T ATE234111T1 AT E234111 T1 ATE234111 T1 AT E234111T1 AT 97929697 T AT97929697 T AT 97929697T AT 97929697 T AT97929697 T AT 97929697T AT E234111 T1 ATE234111 T1 AT E234111T1
- Authority
- AT
- Austria
- Prior art keywords
- trauma
- protein products
- people
- bpi protein
- therapeutic uses
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A61K38/1751—Bactericidal/permeability-increasing protein [BPI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/829—Blood
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US65229296A | 1996-05-23 | 1996-05-23 | |
PCT/US1997/008941 WO1997044056A1 (en) | 1996-05-23 | 1997-05-23 | Therapeutic uses of bpi protein products in humans with hemorrhage due to trauma |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE234111T1 true ATE234111T1 (de) | 2003-03-15 |
Family
ID=24616300
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT97929697T ATE234111T1 (de) | 1996-05-23 | 1997-05-23 | Therapeutische verwendungen von bpi-protein produkten bei menschen mit durch trauma verursachter blutung |
Country Status (10)
Country | Link |
---|---|
US (2) | US5945399A (de) |
EP (1) | EP0907372B1 (de) |
JP (1) | JP2000511190A (de) |
CN (1) | CN1155403C (de) |
AT (1) | ATE234111T1 (de) |
AU (1) | AU736096B2 (de) |
CA (1) | CA2255539C (de) |
DE (1) | DE69719754D1 (de) |
NZ (1) | NZ332954A (de) |
WO (1) | WO1997044056A1 (de) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5198541A (en) * | 1987-08-11 | 1993-03-30 | New York University | Dna encoding bactericidal/permeability-increasing proteins |
US5652332A (en) * | 1993-03-12 | 1997-07-29 | Xoma | Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
US6214789B1 (en) | 1993-03-12 | 2001-04-10 | Xoma Corporation | Treatment of mycobacterial diseases by administration of bactericidal/permeability-increasing protein products |
WO1997004008A1 (en) * | 1995-07-20 | 1997-02-06 | Xoma Corporation | Anti-fungal peptides |
US5888973A (en) * | 1996-08-09 | 1999-03-30 | Xoma Corporation | Anti-chlamydial uses of BPI protein products |
US6482796B2 (en) | 1996-11-01 | 2002-11-19 | Xoma Corporation | Therapeutic uses of N-terminal BPI protein products in ANCA-positive patients |
US6093573A (en) * | 1997-06-20 | 2000-07-25 | Xoma | Three-dimensional structure of bactericidal/permeability-increasing protein (BPI) |
US6528255B1 (en) * | 1997-12-30 | 2003-03-04 | Genencor International, Inc. | Proteases from gram positive organisms |
US6013631A (en) | 1998-06-19 | 2000-01-11 | Xoma Corporation | Bactericidal/permeability-increasing protein (BPI) deletion analogs |
BR9914735A (pt) | 1998-10-22 | 2001-07-03 | Lilly Co Eli | Processo para tratamento de sépsia |
EP1156765A4 (de) * | 1998-11-12 | 2002-08-07 | Polymer Biosciences Inc | Ein zur schnellen blutgerinnung nützlicher blutstillender polymer |
US6162237A (en) * | 1999-04-19 | 2000-12-19 | Chan; Winston Kam Yew | Temporary intravascular stent for use in retrohepatic IVC or hepatic vein injury |
US20020173464A1 (en) * | 2000-12-01 | 2002-11-21 | King George L. | Modulation of pericyte proliferation |
US7101862B2 (en) | 2001-12-31 | 2006-09-05 | Area Laboratories, Llc | Hemostatic compositions and methods for controlling bleeding |
EP1741440A1 (de) | 2005-07-08 | 2007-01-10 | Mellitus S.L. | Verwendung von BPI-proteine zur Behandlung von stoffwechselbedingten Erkrankungen und Herzkreislaufstörungen |
US8106176B2 (en) * | 2005-10-07 | 2012-01-31 | Instituto di Richerche di Biologia Molecolare P. Angeletti SpA | Matrix metalloproteinase 11 vaccine |
CN2887006Y (zh) * | 2005-11-30 | 2007-04-04 | 富士康(昆山)电脑接插件有限公司 | 电子装置的屏蔽构造 |
US20070248653A1 (en) * | 2006-04-20 | 2007-10-25 | Cochrum Kent C | Hemostatic compositions and methods for controlling bleeding |
GB201319621D0 (en) | 2013-11-06 | 2013-12-18 | Norwegian University Of Science And Technology | Antimicrobial agents and their use in therapy |
GB201319620D0 (en) | 2013-11-06 | 2013-12-18 | Norwegian University Of Science And Technology | Immunosuppressive agents and their use in therapy |
CN106020478B (zh) * | 2016-05-20 | 2019-09-13 | 青岛海信电器股份有限公司 | 一种智能终端操控方法、装置和智能终端 |
Family Cites Families (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5245013A (en) * | 1985-04-30 | 1993-09-14 | Richard Ulevitch | Acute phase protein modulating endotoxic activity of lipopolysaccharides, assay methods and polypeptides |
US5198541A (en) * | 1987-08-11 | 1993-03-30 | New York University | Dna encoding bactericidal/permeability-increasing proteins |
DE3853918T2 (de) * | 1987-08-11 | 1996-02-08 | Univ New York | Biologisch aktive bakterientötende/durchlässigkeitserhöhende proteinfragmente. |
US5576292A (en) * | 1987-08-11 | 1996-11-19 | New York University | Biologically active bactericidal/permeability-increasing protein fragments |
US5234912A (en) * | 1989-02-14 | 1993-08-10 | Incyte Pharmaceuticals, Inc. | Pharmaceutical compositions comprising recombinant BPI proteins and a lipid carrier and uses thereof |
US5334584A (en) * | 1989-02-14 | 1994-08-02 | Incyte Pharamaceuticals, Inc. | Recombinant, non-glycosylated bpi protein and uses thereof |
US5171739A (en) * | 1989-02-14 | 1992-12-15 | Incyte Pharmaceuticals, Inc. | Treatment of endotoxin-associated shock and preventation thereof using a BPI protein |
WO1994025476A1 (en) * | 1993-04-30 | 1994-11-10 | Incyte Pharmaceuticals, Inc. | Recombinant bpi-based and lbp-based proteins, nucleic acid molecules encoding same, methods of producing same, and uses thereof |
US5308834A (en) * | 1989-02-14 | 1994-05-03 | Incyte Pharmaceuticals, Inc. | Treatment of endotoxin-associated shock and prevention thereof using a BPI protein |
US5089274A (en) * | 1989-02-14 | 1992-02-18 | Incyte Pharmaceuticals, Inc. | Use of bactericidal/permeability increasing protein or biologically active analogs thereof to treat endotoxin-related disorders |
AU645515B2 (en) * | 1989-08-01 | 1994-01-20 | Rockefeller University, The | Methods and compositions for ameliorating the symptoms of sepsis |
AU9127591A (en) * | 1990-12-03 | 1992-06-25 | New York University | Biologically active bactericidal/permeability-increasing protein fragments |
AU2872792A (en) * | 1991-09-26 | 1993-04-27 | Incyte Pharmaceuticals, Inc. | A new form of liposaccharide binding protein (lbp) |
ATE178652T1 (de) * | 1992-05-19 | 1999-04-15 | Xoma Corp | Verbessertes verfahren zur herstellung von endotoxinbindungsproteinen |
WO1993023434A2 (en) * | 1992-05-19 | 1993-11-25 | Xoma Corporation | Bpi-immunoglobulin fusion proteins |
US5420019A (en) * | 1993-02-02 | 1995-05-30 | Xoma Corporation | Stable bactericidal/permeability-increasing protein muteins |
CA2155005C (en) * | 1993-02-02 | 1999-04-06 | Weldon Courtney Mcgregor | Pharmaceutical compositions containing bactericidal permeability increasing protein and a surfactant |
AU6361894A (en) * | 1993-03-12 | 1994-09-26 | Xoma Corporation | Treatment of mycobacterial diseases by administration of bactericidal/permeability-increasing protein products |
US5348942A (en) * | 1993-03-12 | 1994-09-20 | Xoma Corporation | Therapeutic uses of bactericidal/permeability increasing protein products |
ATE169304T1 (de) * | 1993-03-12 | 1998-08-15 | Xoma Corp | Biologisch aktive peptide aus funktionellen domaenen des bakteriziden/ die permeabilitaet erhoehenden proteins und ihre verwendung |
ATE202482T1 (de) * | 1993-03-12 | 2001-07-15 | Xoma Technology Ltd | Therapeutische verwendungen von antibakteriellen/durchlässigkeitserhöhenden proteinprodukten |
US5733872A (en) * | 1993-03-12 | 1998-03-31 | Xoma Corporation | Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
AU6522794A (en) * | 1993-03-22 | 1994-10-11 | Incyte Pharmaceuticals, Inc. | Use of bactericidal/permeability increasing protein and lipopolysaccharide binding protein levels and ratios thereof in diagnosis |
AU7175694A (en) * | 1993-06-17 | 1995-01-17 | Xoma Corporation | Lipopolysaccharide binding protein derivatives |
DE69431922T2 (de) * | 1993-07-02 | 2003-11-13 | Incyte Pharma Inc | Glycosilierte und nichtglycolisierte bakterizide/die permeabilität erhoehende proteine und methoden zu ihrer herstellung |
AU7330994A (en) * | 1993-07-14 | 1995-02-13 | Xoma Corporation | Method for potentiating bpi protein product bactericidal activity by administration of lbp protein products |
US5466580A (en) * | 1993-09-22 | 1995-11-14 | Xoma Corporation | Method for quantifying BPI in body fluids |
NZ275205A (en) * | 1993-09-22 | 1998-03-25 | Xoma Corp | Use of bactericidal/permeability-increasing protein in treating gram-negative bacterial infection |
CN1133634A (zh) * | 1993-09-22 | 1996-10-16 | 爱克斯欧玛公司 | 定量体液中的bpi的方法 |
CA2173611C (en) * | 1993-10-05 | 2005-07-26 | Paul A. M. Van Leeuwen | Method of treating depressed reticuloendothelial system function |
AU703211B2 (en) * | 1994-01-14 | 1999-03-18 | Xoma Corporation | Anti-fungal methods and materials |
PT754050E (pt) * | 1994-01-14 | 2002-11-29 | Xoma Technology Ltd | Metodos e materiais contra bacterias gram-positivas |
US5643875A (en) * | 1994-01-24 | 1997-07-01 | Friedmann; Nadav | Human therapeutic uses of bactericidal/permeability increasing (BPI) protein products |
US5484705A (en) * | 1994-01-24 | 1996-01-16 | Xoma Corporation | Method for quantifying lipopolysaccharide binding protein |
US5447913A (en) * | 1994-03-11 | 1995-09-05 | Xoma Corporation | Therapeutic uses of bactericidal/permeability-increasing protein dimer products |
US5578568A (en) * | 1994-04-22 | 1996-11-26 | Xoma Corporation | Method of treating conditions associated with intestinal ischemia/reperfusion |
US5532216A (en) * | 1994-06-24 | 1996-07-02 | Incyte Pharmaceuticals, Inc. | Neutralization of non-lipopolysaccharide compounds by bactericidal/permeability-increasing protein |
US5646114A (en) * | 1994-07-11 | 1997-07-08 | Xoma Corporation | Anti-protozoan methods |
CA2200069C (en) * | 1994-09-15 | 2000-09-26 | Roger G. Ii Little | Anti-fungal peptides |
US5912228A (en) * | 1995-01-13 | 1999-06-15 | Xoma Corporation | Therapeutic compositions comprising bactericidal/permeability-increasing (BPI) protein products |
US5494896A (en) * | 1995-03-31 | 1996-02-27 | Xoma Corporation | Method of treating conditions associated with burn injuries |
-
1997
- 1997-05-23 US US08/862,785 patent/US5945399A/en not_active Expired - Fee Related
- 1997-05-23 DE DE69719754T patent/DE69719754D1/de not_active Expired - Lifetime
- 1997-05-23 AT AT97929697T patent/ATE234111T1/de not_active IP Right Cessation
- 1997-05-23 NZ NZ332954A patent/NZ332954A/xx unknown
- 1997-05-23 AU AU33693/97A patent/AU736096B2/en not_active Ceased
- 1997-05-23 CA CA002255539A patent/CA2255539C/en not_active Expired - Fee Related
- 1997-05-23 EP EP97929697A patent/EP0907372B1/de not_active Expired - Lifetime
- 1997-05-23 JP JP09542841A patent/JP2000511190A/ja active Pending
- 1997-05-23 WO PCT/US1997/008941 patent/WO1997044056A1/en active IP Right Grant
- 1997-05-23 CN CNB971957282A patent/CN1155403C/zh not_active Expired - Fee Related
- 1997-09-10 US US08/927,438 patent/US5756464A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DE69719754D1 (de) | 2003-04-17 |
US5756464A (en) | 1998-05-26 |
CN1222859A (zh) | 1999-07-14 |
EP0907372B1 (de) | 2003-03-12 |
EP0907372A1 (de) | 1999-04-14 |
AU3369397A (en) | 1997-12-09 |
US5945399A (en) | 1999-08-31 |
WO1997044056A1 (en) | 1997-11-27 |
CA2255539A1 (en) | 1997-11-27 |
CN1155403C (zh) | 2004-06-30 |
NZ332954A (en) | 2000-07-28 |
CA2255539C (en) | 2005-09-27 |
AU736096B2 (en) | 2001-07-26 |
JP2000511190A (ja) | 2000-08-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE234111T1 (de) | Therapeutische verwendungen von bpi-protein produkten bei menschen mit durch trauma verursachter blutung | |
DK0914144T3 (da) | Terapeutiske anvendelser af BPI-protein-produkter til human meningokokæmi | |
ATE257390T1 (de) | Verwendung eines bpi proteinproduktes als antithrombotisches mittel | |
WO1998026747A3 (en) | Superantigen based methods and compositions for treatment of diseases | |
NO20016007L (no) | Rekombinant anti-CD40-antistoff og anvendelser derav | |
EP1129718A3 (de) | Therapeutische Verwendungen von Antibakteriellen/Durchlässigkeitserhöhenden Proteinprodukten | |
DE69731373D1 (de) | Cc-chemokinzeptor c-c ckr-5, dessen derivate und verwendungen | |
GB9516287D0 (en) | Pharmaceutical compositon | |
WO1992018160A3 (en) | Method for inhibiting adhesion of white blood cells to endothelial cells | |
EP1918300A3 (de) | Auf Peptiden basierende Immunisierungstherapie zur Behandlung von Atherosklerose | |
BR9907995A (pt) | Métodos imunológicos para modular miostatina em sujeitos vertebrados | |
DK0764209T3 (da) | Albuminekspression i gær | |
DE69410254D1 (de) | Behandlung von mycobakteriellen erkrankungen durch verabreichung von bakrerientötende, durchlässigkeitserhöhende proteinfragmente | |
ATE255126T1 (de) | Unterdrückung von immunantwort durch hemmung von cathepsin s | |
ATE286510T1 (de) | In der behandlung von il4 auslösenden krankheiten nützliche rekombinante il4 antikörper | |
DE69526216D1 (de) | Antifungaleverfahren und mitteln | |
DE69431603D1 (de) | Oligopeptide hergeleitet von fragmenten des c-reaktiven proteins | |
WO1996020950A3 (en) | Compositions and methods for treating rheumatoid arthritis | |
BG103905A (en) | New bpc peptide salts with organoprotective activity, method for their preparation and application in medicine | |
BR0013665A (pt) | Uso de uma proteìna histacalina, composição farmacêutica, e, método de tratar ou impedir conjuntivite | |
GB9723824D0 (en) | Cytostatic agents | |
FR2708283B1 (fr) | Compositions pharmaceutiques et leur utilisation, notamment pour le traitement des maladies neurodégénératives. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |